Stock Locations

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

90357-51-0Bicalutamide Oxirane Impurity

● In Stock

Catalogue No.:	VE006823
CAS No.:	90357-51-0
Mol. Formula:	C12H9F3N2O2
Mol. Weight:	270.21 g/mol

Request a quote

Add to RFQ list

Additional information on CAS 90357-51-0

Parent drug

Bicalutamide

IUPAC Name

N-[4-Cyano-3-(trifluoromethyl)phenyl]-2-methyl-2-oxiranecarboxamide

Smiles

O=C(C1(C)OC1)NC2=CC=C(C#N)C(C(F)(F)F)=C2

InChI

InChI=1S/C12H9F3N2O2/c1-11(6-19-11)10(18)17-8-3-2-7(5-16)9(4-8)12(13,14)15/h2-4H,6H2,1H3,(H,17,18)

Shipping Condition

Ambient Temperature

Characterization Data (Included)

HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, and Structure Elucidation Report (SER).

Additional Characterization Data

QNMR, D2O Exchange, 13C NMR, 13C APT, COSY NMR, NOESY NMR, 15N NMR, HSQC NMR, HMQC NMR, and HMBC NMR. These are available upon request and may be free or subject to additional charges.

Description

It is an associate impurity Bicalutamide. Bicalutamide is used together with a luteinizing hormone-releasing hormone (LHRH) analog (eg, goserelin or leuprolide) to treat stage D2 metastatic prostate cancer (cancer that has spread) in men. Bicalutamide belongs to the group of medicines called antiandrogens.